Ablation of ovomucoid-induced allergic response by desensitization with recombinant ovomucoid third domain in a murine model

Clinical and Experimental Immunology

Volumn 145, Issue 3, 2006, Pages 493-501

  Rupa, P ^a   Mine, Y ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cytokines; Desensitization; Egg allergy; IgE; Immunotherapy; Ovomucoid; Th1 Th2

Indexed keywords

ALLERGEN; AMINO ACID; ANTIBODY; CYTOKINE; EPITOPE; GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; OVOMUCOID; RECOMBINANT OVOMUCOID; UNCLASSIFIED DRUG;

ALLERGENICITY; ALLERGIC REACTION; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESENSITIZATION; EGG ALLERGY; FEMALE; GENE MUTATION; HISTAMINE BLOOD LEVEL; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SENSITIZATION; SUPPRESSOR CELL; TH1 CELL; TH2 CELL;

ANIMALS; DESENSITIZATION, IMMUNOLOGIC; EPITOPES, B-LYMPHOCYTE; FEMALE; HISTAMINE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OVOMUCIN; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 33747424314     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03163.x     Document Type: Article

References (25)

1. Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004; 114:127-30.
2. Munoz-Furlong A, Sampson HA, Sicherer SH. Prevalence of self reported seafood allergy in the U.S. J Clin Allergy Immunol 2004; 113:S100.
3. Hefle S, Nordlee J, Taylor S. Allergenic foods. Crit Rev Food Sci Nutr 1996; 36:S69-89.
4. Kato I, Schrode J, William J, Kohr WJ, Laskowski M Jr. Chicken ovomucoid: determination of its amino acid sequence, determination of the trypsin reactive site, and preparation of all three of its domains. Biochemistry 1987; 26:193-201.
5. Takagi K, Teshima R, Okunuki H, Sawada J. Comparative study of in vitro digestibility of food proteins and effect of preheating on the digestion. Biol Pharm Bull 2003; 26:969-73.
6. Mine Y, Zhang JW. Comparative studies on antigenicity and allergenicity of native and denatured egg white proteins. J Agric Food Chem 2002; 50:2679-83.
7. Zhang JW, Mine Y. Characterization of IgE and IgG epitopes on ovomucoid using egg-white-allergic patients' sera. Biochem Biophys Res Commun 1998; 253:124-7.
8. Besler M, Steinhart H, Paschke A. Allergenicity of hen's egg white proteins: IgE-binding of native and deglycosylated ovomucoid. Food Agric Immunol 1997; 9:277-88.
9. Takagi K, Teshima R, Okunuki H et al. Kinetic analysis of pepsin digestion of chicken egg white ovomucoid and allergenic potential of pepsin fragments. Int Arch Allergy Immunol 2005; 136:23-32.
10. Bannon GA, Cockrell G, Connaughton C et al. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int Arch Allergy Immunol 2001; 124:70-2.
11. Ruoppi P, Virtanen T, Zeiler T et al. In vitro and in vivo responses to the major bovine dander allergen Bos d2 and its fragments. Clin Exp Allergy 2001; 31:915-9.
12. Orlandi A, Grasso F, Corinti S et al. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization. Clin Exp Allergy 2004; 34:470-7.
13. Mine Y, Sasaki E, Zhang JW. Reduction of antigenicity and allergenicity of genetically modified egg white allergen, ovomucoid third domain. Biochem Biophys Res Commun 2003; 302:133-7.
14. Fredericq E, Deutsch HF. Studies on ovomucoid. J Biol Chem 1949; 181:499-510.
15. Mine Y, Zhang JW. Identification and fine mapping of IgG and IgE epitopes in ovomucoid. Biochem Biophys Res Commun 2002; 292:1070-4.
16. Nelson HS, Lahr J, Rule R et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99:744-51.
17. Crespo JF, James JM, Rodriguez J. Diagnosis and therapy of food allergy. 2004; 48:347-55.
18. Van Oosterhout AJ, van Esch B, Hofman G et al. Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1998; 19:622-8.
19. Steinke JW, Borish L. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2001; 2:6670.
20. Gately MK, Renzetti LM, Magram J et al. The interleukin-12/interleukin- 12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16:495521.
21. Kalinski PC, Hilkens M, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999; 20:561-7.
22. Kim TS, DeKruyff RH, Rupper R, Maecker HT, Levy S, Umetsu DT. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 1997; 158:4137-44.
23. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102:98-106.
24. Jutel M, Akdis M, Budak F et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-14.
25. Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003; 111:1255-61.